Drugmaker Endo Signs $65 Million Opioid Settlement with Florida
The deal is the latest in a string of settlements that Endo has struck in recent months to resolve similar cases, including a $63 million settlement with Texas in December.
The Florida settlement included no admission of wrongdoing, Endo said, while reiterating that its goal was to achieve a global opioid settlement.
Thousands of lawsuits have been filed seeking to hold drugmakers, drug distributors and pharmacy chains responsible for a drug abuse crisis, which the U.S. government says has led to hundreds of thousands of overdose deaths over two decades.
Endo shares rose nearly 4% to $3.40 in premarket trading.
The settlement comes less than a month after Texas officials announced a $63 million settlement with Endo. The settlement requires Endo to pay into the Texas State Qualified Settlement Fund—which will disperse funding accordingly—without a requirement of a global settlement first, a news release said.
- Work Safety Group Releases List of ‘Dirty Dozen’ Employers
- Jury Awards $80M to 3 Former Zurich NA Employees for Wrongful Termination
- Warren Buffett’s PacifiCorp Now Faces $30 Billion Fire Claim Demand
- New Vehicle Registrations in California Rose, While Tesla Registrations Dropped Again
- CoreLogic Report Probes Evolving Severe Convective Storm Risk Landscape
- Millions of Recalled Hyundai and Kia Vehicles, With Dangerous Defect, Remain on Road
- Apollo Accused in Lawsuit of Illegal Human Life Wagering Scheme
- Report: Vehicle Complexity, Labor ‘Reshaping’ Auto Insurance and Collision Repair